CBM BIOPHARMA
The CBM drug portfolio focuses on the treatment of three cancers, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and pancreatic cancer. Our AML drug is a next generation targeted therapeutic designed to overcome multiple resistance mechanisms observed with the current standard of care. Our pancreatic treatment has shown positive preclinical results for inhibiting pancreatic tumor growth in clinically relevant transgenic mouse models. The drug has also demonstrated the potential to overcome tumor cell resistance to current chemotherapeutic drugs.
CBM BIOPHARMA
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.cbmbiopharmainc.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Mobile Non Scaleable Content Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Official Site Inspections
http://www.cbmbiopharmainc.com
- Host name: 121.46.124.133
- IP address: 121.46.124.133
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
